The U.S. Food and Drug Administration has approved the use of Januvia tablets as the first in a new class of diabetes drugs.
The new drugs, known as DDP-4 inhibitors, enhance the body's ability to lower elevated blood sugar.
The FDA said it approved Januvia (sitagliptin phosphate) for use by patients with type 2 diabetes, alone or in combination with two other commonly prescribed oral diabetes medications -- metformin or a PPAR (peroxisome proliferator-activated receptor gamma) agonist -- when either of those drugs doesn't provide adequate blood sugar control.
Type 2 diabetes is the most common form of the disease, accounting for about 90 percent to 95 percent of all cases of diabetes. In type 2 diabetes, the body does not produce enough insulin or the cells ignore the insulin.
Januvia was examined in 2,719 patients with type 2 diabetes during in studies lasting to more than a year. The studies demonstrated improved blood sugar control when Januvia was used alone or in patients not satisfactorily managed with metformin or a PPAR agonist.
The most common side effects were upper respiratory tract infection, sore throat, and diarrhea.
Januvia is manufactured by Merck and Co. Inc.
Copyright 2006 by United Press International
Related stories:
Proteins involved in blood vessel dysfunction in type 2 diabetes are identified
According to the American Heart Association, three-fourths of people with diabetes die of some form of heart or blood-vessel disease. Previous studies have shown that cardiac function is compromised and cardiovascular diseases are increased in people with type 2 diabetes. Before vascular diseases develop in diabetics, blood-vessel cell dysfunction occurs. Using precise microscopes, University of Missouri researchers are dissecting coronary microvessels and testing which proteins are responsible for inflammation that causes blood-vessel dysfunction. By identifying the proteins that play important roles in blood-vessel dysfunction, they hope to develop new treatments for blood-vessel dysfunction in people with type 2 diabetes.
Too many calories send the brain off kilter
An overload of calories throws critical portions of the brain out of whack, reveals a study in the October 3rd issue of the journal
Cell, a Cell Press publication. That response in the brain's hypothalamus—the "headquarters" for maintaining energy balance -- can happen even in the absence of any weight gain, according to the new studies in mice.
Scientists discover why a mother's high-fat diet contributes to obesity in her children
New research published online in
The FASEB Journal suggests that pregnant women should think twice about high-fat foods. In a study from the University of Cincinnati and the Medical College of Georgia, scientists found that female mice fed high fat diets were more likely to have oversized offspring (a risk factor for overweight and obesity) because fat causes the placenta to go into "overdrive" by providing too many nutrients to the fetus. This information also suggests that the reverse may be true as well—high fat diets may help prevent undersized babies.
Mexico pushes national campaign to lose weight
(AP) -- Abraham Leon was getting a checkup when he found out he had high blood pressure and was at risk of developing diabetes.
Existing anti-obesity drugs may be effective against flu, hepatitis and HIV
Viruses dramatically increase cellular metabolism, and existing anti-obesity drugs may represent a new way to block these metabolic changes and inhibit viral infection, according to a study published today in the journal
Nature Biotechnology.
Continuous glucose monitoring in diabetic pregnant women lowers risk of complications
Continuous glucose monitoring as part of antenatal care for women with diabetes improves maternal blood glucose control and lowers birth weight and risk of macrosomia (excessive birth weight in babies), according to a study published on bmj.com today.
Inhibiting cholesterol-associated protein reduces high-risk blockages in arteries
Using the drug darapladib, researchers at the University of Pennsylvania School of Medicine and colleagues have inhibited a cholesterol-and immune system-associated protein, thereby reducing the development of heart-disease plaques that may cause death, heart attacks, and strokes in a pig model of atherosclerosis and diabetes. The study appeared online this week in
Nature Medicine.
People with type 2 diabetes can put fatty livers on a diet with moderate exercise
Weekly bouts of moderate aerobic exercise on a bike or treadmill, or a brisk walk, combined with some weightlifting, may cut down levels of fat in the liver by up to 40 percent in people with type 2 diabetes, a study by physical fitness experts at Johns Hopkins shows.